Expression of connective tissue growth factor in male breast cancer: Clinicopathologic correlations and prognostic value

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Lacle, Miangela M ^a   Van Diest, Paul J ^a   Goldschmeding, Roel ^a   Van Der Wall, Elsken ^a   Nguyen, Tri Q ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PROGNOSIS; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; PROGNOSTIC ASSESSMENT; PROTEIN EXPRESSION; TUMOR CELL; BREAST NEOPLASMS, MALE; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS, MALE; CONNECTIVE TISSUE GROWTH FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 84929492487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118957     Document Type: Article

References (22)

1. Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 1993 Jul 26; 327(2):125-30. PMID: 7687569
2. Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, Yin D, et al. Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol. 2011 Jun; 38(6):1741-7. doi: 10.3892/ijo.2011.985 PMID: 21455569
3. Perbal B. CCN proteins: A centralized communication network. J Cell Commun Signal. 2013 Aug; 7 (3):169-77. doi: 10.1007/s12079-013-0193-7 PMID: 23420091
4. Yeger H, Perbal B. The CCN family of genes: a perspective on CCN biology and therapeutic potential. J Cell Commun Signal. 2007 Dec; 1(3-4):159-64. doi: 10.1007/s12079-007-0005-z PMID: 18481209
5. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res. 2001 Dec 15; 61(24):8917-23. PMID: 11751417
6. Shaaban AM, Ball GR, Brannan RA, Cserni G, Di Benedetto A, Dent J, et al. A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences. Breast Cancer Res Treat. 2012 June; 133(3):949-58. doi: 10.1007/s10549-011-1856-9 PMID: 22094935
7. Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, et al. Molecular subtyping of male breast cancer by immunohistochemistry. Mod Pathol. 2012 Mar; 25(3):398-404. doi: 10.1038/modpathol.2011.174 PMID: 22056953
8. Kornegoor R, Moelans CB, Verschuur-Maes AH, Hogenes MC, de Bruin PC, Oudejans JJ, et al. Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification. Breast Cancer Res. 2012 Jul 5; 14(4):R101. doi: 10.1186/bcr3220 PMID: 22765268
9. Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ, et al. Fibrotic focus and hypoxia in male breast cancer. Mod Pathol. 2012 Jun 8.
10. Kornegoor R, Moelans CB, Verschuur-Maes AH, Hogenes MC, de Bruin PC, Oudejans JJ, et al. Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification. Breast Cancer Res Treat. 2012 Aug; 135(1):49-58. doi: 10.1007/s10549-012-2051-3 PMID: 22527098
11. Weber-Chappuis K, Bieri-Burger S, Hurlimann J. Comparison of prognostic markers detected by immunohistochemistry in male and female breast carcinomas. Eur J Cancer. 1996 Sep; 32A(10):1686-92. PMID: 8983275
12. Lacle MM, Kornegoor R, Moelans CB, Maes-Verschuur AH, van der Pol C, Witkamp AJ, et al. Analysis of copy number changes on chromosome 16q in male breast cancer by multiplex ligation-dependent probe amplification. Mod Pathol. 2013 Nov; 26(11):1461-7. doi: 10.1038/modpathol.2013.94 PMID: 23743929
13. Bocker W. WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics. Verh Dtsch Ges Pathol. 2002; 86:116-9. PMID: 12647359
14. Central Committee on Research involving Human Subjects.
15. van Diest PJ. No consent should be needed for using leftover body material for scientific purposes. For. BMJ. 2002 Sep 21; 325(7365):648-51.
16. Lacle MM, van der Pol C, Witkamp A, van der Wall E, van Diest PJ. Prognostic value of mitotic index and Bcl2 expression in male breast cancer. PLOS One. 8(4):e60138. doi: 10.1371/journal.pone. 0060138 PMID: 23573235
17. Boersema M, Katta K, Rienstra H, Molema G, Nguyen TQ, Goldschmeding R, et al. Local medial microenvironment directs phenotypic modulation of smooth muscle cells after experimental renal transplantation. Am J Transplant. 2012 Jun; 12(6):1429-40. doi: 10.1111/j.1600-6143.2012.04001.x PMID: 22420764
18. Frazier KS, Grotendorst GR. Expression of connective tissue growth factor mRNA in the fibrous stroma of mammary tumors. Int J Biochem Cell Biol. 1997 Jan; 29(1):153-61. PMID: 9076950
19. Capparelli C, Whitaker-Menezes D, Guido C, Balliet R, Pestell TG, Howell A, et al. CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth. Cell Cycle. Jun 15; 11(12):2272-84. doi: 10.4161/cc.20717 PMID: 22684333
20. Xiu M, Liu YH, Brigstock DR, He FH, Zhang RJ, Gao RP. Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth. World J Gastroenterol. 2012 Dec 21; 18(47):7070-8. doi: 10.3748/wjg.v18.i47.7070 PMID: 23323010
21. Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng ZQ, et al. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo. Chin Med J (Engl). 2011 Nov; 124(22):3794-9. PMID: 22340243
22. Johansson I, Nilsson C, Berglund P, Lauss M, Ringner M, Olsson H, et al. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Res. 14(1):R31. PMID: 22333393